Decreased hepatic glucagon responses in Type 1 (insulin-dependent) diabetes mellitus

Diabetologia

Volumn 34, Issue 7, 1991, Pages 521-526

  Orskov L ^a   Alberti, K G M M ^b   Mengel, A ^c   Moller N ^c   Pedersen, O ^d   Rasmussen, O ^c   Seefeldt, T ^a   Schmitz, O ^e  

^a Randers Centralsygehus ^*  (Denmark)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c AARHUS UNIVERSITY   (Denmark)

^d STENO DIABETES CENTER   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Glucagon; Hepatic glucose production; Type 1 diabetes mellitus

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; SOMATOSTATIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

3-HYDROXYBUTYRIC ACID; ADULT; ALANINE; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, INSULIN-DEPENDENT; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCAGON; GLUCOSE; GLYCEROL; GROWTH HORMONE; HUMAN; HYDROXYBUTYRATES; INFUSIONS, INTRAVENOUS; INSULIN; KINETICS; LACTATES; LIVER; MALE; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0025886615     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF00403290     Document Type: Article

References (40)

1. Glucose counter regulation and its impact in diabetes mellitus
2. Frequency of daytime biochemical hypoglycaemia in insulin-treated diabetic patients in relation to daily median plasma glucose concentrations
3. Hormonal mechanisms for the recovery from insulin induced hypoglycaemia in man
4. Hormonal mechanisms in acute glucose counter regulation: the relative roles of glucagon, epinephrine, norepinephrine, growth hormone and cortisol
5. Influence of continuous physiologic hyperinsulinaemia on glucose kinetics and counter regulatory hormone responses in normal and diabetic humans
6. Role of glucagon, catecholamines and growth hormone in human glucose counter regulation
7. The pancreaticadrenocortical-pituitary clamp technique for study of counterregulation in humans
8. Contribution of cortisol to glucose counterregulation in humans
9. Demonstration of a role for growth hormone in glucose counterregulation
10. The role of autoregulation of the hepatic glucose production in man's response to a physiological decrement in plasma glucose
11. Role of hepatic autoregulation in defence against hypoglycaemia in human
12. Hypoglycaemia and glucose counter regulation in normal and insulin-dependent diabetic subject
13. Hypoglycaemia in IDDM. A conference summary
14. Abnormal glucose counter regulation in IDDM. Interaction of antiinsulin antibodies and impaired glucagon secretion
15. Defective glucose counter regulation after subcutaneous insulin in non-insulin-dependent diabetes mellitus
16. Identification of type 1 diabetic patients at increased risk for hypoglycaemia during intensive therapy
17. The significance of impaired pancreatic polypeptide and epinephrine responses to hypoglycaemia in patients with IDDM
18. Insulin, glucagon and glucose as regulators of hepatic glucose uptake and production in vivo
19. Substrate turnover during prolonged exercise in man
20. Glucagon, not insulin may play a secondary role in defense against hypoglycemina during exercise
21. Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast
22. Synergistic actions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans
23. Importance of hypoglycaemia-induced glucose production during isolated glucagon deficiency
24. Wick-chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone
25. Insulin resistance in uraemic insulin dependent diabetics. Effect of dialysis therapy as assessed by the artificial endocrine pancreas
26. A simple and ultrasensitive method for determination of free fatty acids by radiochemical assay
27. Blood glucose, lactate, pyruvate, glycerol, 3-hydroxybutyrate and acetoacetate measurements in man using a centrifugal analyser with a fluorimetric attachment
28. Influence of glucose loading and of injected insulin on hepatic glucose output
29. Altered responsiveness to cortisol, epinephrine and glucagon in insulin infused juvenile onset diabetics. A mechanism for diabetic instability
30. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uremic subjects
31. The effects of chronic uremia on glucagon binding and action in isolated rat hepatocytes
32. Differential time course of glucagon effect on glycogenolysis and gluconeogenesis in the conscious dog
33. Contributions of gluconeogenesis and glycogenolysis during glucose counterregulation in normal humans
34. Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes
35. Hepatic and peripheral insulin resistance: a common feature of Type 2 (noninsulin-dependent) and Type 1 (insulin-dependent) diabetes mellitus
36. Enhanced hepatic insulin sensitivity, bul peripheral insulin resistance in patients with Type 1 (insulin-dependent) diabetes
37. The effect of hyperglycaemia independent of changes in insulin or glucagon on lipolysis in the conscious dog
38. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism
39. The physiological function of glucagon